Abstract
Purpose
The aim of this study is to investigate the association between hydrochlorothiazide (HCTZ) use and the risk of cutaneous and lip squamous cell carcinoma development.
Methodology
We performed a systematic review and meta-analysis of case–control studies. We searched the Cochrane Library, PubMed, Scopus, Web of Science and LILACS. This study was registered in PROSPERO under protocol CRD42019129710. The meta-analysis was performed using the software Stata (version 12.0).
Results
A total of 2181 published studies referring to the theme were identified, from which six were included in this systematic review. Men were more frequently affected by cutaneous and lip squamous cell carcinoma than women, with a 1.42:1 ratio. The mean age for cutaneous and lip squamous cell carcinoma development was 73.7 years. This meta-analysis demonstrated a chance of developing cutaneous and lip squamous cell carcinoma in any region of the body in hydrochlorothiazide users of 1.76-fold higher than in non-users. In addition, a risk factor of 1.80 higher (CI 95% = 1.71–1.89) of cutaneous squamous cell carcinoma in the head and neck region was observed in HCTZ users. Moreover, in the analysis of the dose used, the chance of developing squamous cell carcinoma was 3.37-fold lower when the concentration of HCTZ used was less than 50,000 mg.
Conclusions
Our results confirm the association between the use of hydrochlorothiazide and the cutaneous and lip squamous cell carcinoma development.
Similar content being viewed by others
References
Liu-Smith F, Jia J, Zheng Y (2017) UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. In: Ultraviolet Light in Human Health, Diseases and Environment. Springer. p. 27–40
Que SKT, Zwald FO, Schmults CD (2018) Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol 78(2):237–247
Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA (2016) Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis. JAMA Otolaryngol Neck Surg 142(12):1216–1223
Nguyen KD, Han J, Li T, Qureshi AA (2014) Invasive cutaneous squamous cell carcinoma incidence in US health care workers. Arch Dermatol Res 306(6):555–560
Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE et al (2014) Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20(24):6582–6592
Karia PS, Han J, Schmults CD (2013) Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 68(6):957–966
López EPM, Miñarro-Del Moral RM, Martínez-García C, Zanetti R, Rosso S, Serrano S et al (2003) Lifestyles, environmental and phenotypic factors associated with lip cancer: A case-control study in southern Spain. Br J Cancer 88(11):1702–1707
Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA (2013) Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 149(5):541–547
Shin D, Lee ES, Kim J, Guerra L, Naik D, Prida X (2019) Association between the use of thiazide diuretics and the risk of skin cancers: A meta-analysis of observational studies. J Clin Med Res 11(4):247–255
Blakely KM, Drucker AM, Rosen CF (2019) Drug-induced photosensitivity—an update: culprit drugs, prevention and management. Drug Saf 1–21
Wright J, Musini V, Gill R (2018) First-line drugs for hypertension. Summary of findings for the main comparison. Cochrane Database Syst Rev (4)
Gómez-Bernal S, Álvarez-Pérez A, Rodríguez-Pazos L, Gutiérrez-González E, Rodríguez-Granados MT, Toribio J (2014) Fotosensibilidad por tiazidas. Actas Dermosifiliogr 105(4):359–366
Kunisada M, Masaki T, Ono R, Morinaga H, Nakano E, Yogianti F et al (2013) Hydrochlorothiazide enhances UVA-induced DNA damage. Photochem Photobiol 89(3):649–654
Cognetta ABJ, Wolfe CM, Heinrichs E (2016) Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon’s Concern. Dermatol Surg 42(9):1107–1109
Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6(7)
Fowkes FG, Fulton PM (1991) Critical appraisal of published research: introductory guidelines. BMJ Br Med J 302(6785):1136
Jensen AØ, Thomsen HF, Engebjerg MC, Olesen AB, Sørensen HT, Karagas MR (2008) Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study. Br J Cancer 99(9):1522
Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA (2012) Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med 172(16):1246–1251
Pottegard A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD et al (2017) Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med 282(4):322–331
Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A (2018) Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol 78(4):673–681.e9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043483819&doi=10.1016%2Fj.jaad.2017.11.042&partnerID=40&md5=838420359eecceab374e6253d9a5a9a7. Accessed 2 Mar 2022
Morales D, Pacurariu A, Slattery J, Kurz X (2020) Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population‐based nested case‐control studies. Br J Clin Pharmacol
Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR (2013) Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case–control study. J Invest Dermatol 133(8):1950–1955
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Drugs and Herbal Products. Lyon (FR): International Agency for Research on Cancer (2016) (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 108.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK350406/. Accessed 2 Mar 2022
Pedersen SA, Johannesdottir Schmidt SA, Holmich LR, Friis S, Pottegard A, Gaist D (2019) Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study. J Am Acad Dermatol 80(2):460-465.e9
Klop WMC, Elshot YS, Beck A-JCC, Brandsen RE, Lohuis PJFM (2019) Oncodermatology of the Head and Neck. Facial Plast Surg 35(04):368–376
Pereira MG, Galvão TF (2014) Heterogeneidade e viés de publicação em revisões sistemáticas. Epidemiol e Serviços Saúde 23:775–778
Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166(5):1069–1080
Gallagher RP, Lee TK, Bajdik CD, Borugian M (2010) Ultraviolet radiation. Chronic Dis Inj Can 29
Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H et al (1996) The multicentre south European study’Helios’. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 73(11):1447
Ramos J, Villa J, Ruiz A, Armstrong R, Matta J (2004) UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Prev Biomarkers 13(12):2006–2011
Brenner M, Hearing VJ (2008) The protective role of melanin against UV damage in human skin. Photochem Photobiol 84(3):539–549
Vasudev B, Hariharan S (2007) Cancer after renal transplantation. Curr Opin Nephrol Hypertens 16(6):523–528
De Hertog SAE, Wensveen CAH, Bastiaens MT, Kielich CJ, Berkhout MJP, Westendorp RGJ et al (2001) Relation between smoking and skin cancer. J Clin Oncol 19(1):231–238
Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, Spencer SK et al (2007) Occupation and keratinocyte cancer risk: a population-based case–control study. Cancer Causes Control 18(8):895–908
Leonardi-Bee J, Ellison T, Bath-Hextall F (2012) Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol 148(8):939–946
Acknowledgements
The authors thank the National Council for Scientific and Technological Development (CNPq, Brazil), and the Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil).
Author information
Authors and Affiliations
Contributions
Andrade, Felix and França had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Andrade, Felix and França. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: All authors. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Ribeiro and Andrade. Obtained funding: no one. Supervision, and administrative, technical, or material support: Costa, Castro and Barboza.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent to publish
Not applicable.
Statement of prior presentation
The work here has not been previously published
Conflict of interest disclosures
The authors declare no conflict of interest during the time involving the work, from initial conception and planning to present.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
de Macedo Andrade, A.C., Felix, F.A., França, G.M. et al. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis. Eur J Clin Pharmacol 78, 919–930 (2022). https://doi.org/10.1007/s00228-022-03299-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-022-03299-x